Additionally, our data showing that LEAP-2 was able to suppress food intake in ob/ob mice is quite interesting since it shows that its effect is independent of endogenous leptin tone raising the possibility of LEAP-2 based drugs as potential candidates for management of leptin deficiency or leptin resistant related obesity. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.